We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
+23.01%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$1.94B
AUM Growth
+$900M
Cap. Flow
+$775M
Cap. Flow %
39.93%
Top 10 Hldgs %
51.62%
Holding
194
New
73
Increased
41
Reduced
31
Closed
42

Top Buys

Rank Stock Value
1
COO icon
Cooper Companies
COO
+$24.5M
2
PPD
PPD, Inc. Common Stock
PPD
+$19M
3
OM icon
Outset Medical
OM
+$18.6M
4
AFIB
Acutus Medical Inc
AFIB
+$16.2M
5
VCEL icon
Vericel Corp
VCEL
+$14.9M

Top Sells

Rank Stock Value
1
LHCG
LHC Group LLC
LHCG
+$8.66M
2
INSP icon
Inspire Medical Systems
INSP
+$8.51M
3
LIVN icon
LivaNova
LIVN
+$7.29M
4
OSUR icon
OraSure Technologies
OSUR
+$6.64M
5
BSX icon
Boston Scientific
BSX
+$6.44M

Sector Composition

Rank Sector Weight
1 Healthcare 31.67%
2 Industrials 0.76%
3 Consumer Staples 0.45%
4 Energy 0.25%
5 Consumer Discretionary 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VSTM icon
176
Verastem
VSTM
$629M
– –
-41,782
Closed -$862K
ZYME icon
177
Zymeworks
ZYME
$1.77B
– –
-20,500
Closed -$739K
NVRO
178
PUT
DELISTED
NEVRO CORP.
NVRO
– –
-71,000
Closed -$8.48M
RVNC
179
DELISTED
Revance Therapeutics, Inc.
RVNC
– –
-40,900
Closed -$999K
NVTA
180
CALL
DELISTED
Invitae Corporation
NVTA
– –
-205,000
Closed -$6.21M
GTH
181
DELISTED
Genetron Holdings Limited ADS
GTH
– –
-72,267
Closed -$2.62M
ZYNE
182
CALL
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
– –
-239,300
Closed -$806K
NUVA
183
PUT
DELISTED
NuVasive, Inc.
NUVA
– –
-37,500
Closed -$2.09M
STSA
184
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
– –
-27,872
Closed -$802K
XENT
185
CALL
DELISTED
Intersect ENT, Inc
XENT
– –
-102,000
Closed -$1.38M
XLRN
186
DELISTED
Acceleron Pharma
XLRN
– –
-20,400
Closed -$1.94M
FLXN
187
DELISTED
Flexion Therapeutics, Inc.
FLXN
– –
-122,800
Closed -$1.61M
SRACU
188
DELISTED
Stable Road Acquisition Corp. Unit
SRACU
– –
-74,070
Closed -$748K
CNST
189
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
– –
-40,900
Closed -$1.23M
MYOK
190
DELISTED
MyoKardia, Inc. Common Stock
MYOK
– –
-28,800
Closed -$2.78M
IMMU
191
CALL
DELISTED
Immunomedics Inc
IMMU
– –
-102,000
Closed -$3.62M
MNTA
192
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
– –
-149,514
Closed -$4.97M
4 5 6 7
8

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q3 2020 Portfolio in Review

As of Q3 2020, Pura Vida Investments held 194 positions worth $1.94B, up 87% from $1.04B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Pura Vida Investments deployed $775M of net new capital in Q3 2020, opening 73 new positions and adding to 41 existing holdings. Its largest new stake was Cooper Companies: 320,000 shares worth $27M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 38% a quarter earlier, followed by Industrials and Consumer Staples.

On the sell side, the largest reduction was LHC Group LLC, an estimated $8.66M trimmed.

  • Pura Vida Investments's largest Q3 2020 buy was Cooper Companies: 320,000 shares worth $27M.
  • Pura Vida Investments added most to Quotient Limited Ordinary Shares in Q3 2020, an estimated $11.6M increase.
  • Pura Vida Investments's biggest Q3 2020 reduction was LHC Group LLC, cutting an estimated $8.66M.
  • Pura Vida Investments fully exited LivaNova in Q3 2020, selling an estimated $7.29M.
  • Pura Vida Investments's ten largest holdings make up 52% of its $1.94B portfolio in Q3 2020.
  • Pura Vida Investments opened 73 new positions and closed 42 in Q3 2020.
  • Pura Vida Investments's portfolio value rose 87% quarter-over-quarter to $1.94B.

Based on Pura Vida Investments's 13F filing for Q3 2020, filed 16 Nov 2020.